Evidence map›Paper›PMID 41184502›Full record

ArticleEMBO reports2025

Early-stage lung adenocarcinoma affects DNA methylation and gene expression in adjacent tissues.

Yifan Wu, Yadong Wang, Yao Tang, Jianchao Xue, Zichen Jiao, Bowen Li, Sainan Wang, Zhicheng Huang, Xiaoyi Zheng, Chenzheng Guan and 12 more

Abstract read
In one paragraph

Article in EMBO reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yifan Wu *The State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.ORCID 0000-0002-2938-8323
Yadong Wang *Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Yao Tang *Department of Thoracic Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.ORCID 0000-0002-4250-3605
Jianchao Xue *Department of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.ORCID 0000-0001-9818-9101
Zichen JiaoThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Bowen LiDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Sainan WangThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Zhicheng HuangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Xiaoyi ZhengThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Chenzheng GuanThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
Daoyun WangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Ji LiDepartment of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Lan SongDepartment of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Ka Luk FungDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Heqing XuDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Shanqing LiDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Liucun ZhuSchool of Life Sciences, Shanghai University, Shanghai, China.
Jian-Qun ChenThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
David J KerrRadcliffe Department of Medicine, University of Oxford, Oxford, UK.
Naixin LiangDepartment of Thoracic Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China. liangnaixin@pumch.cn.ORCID 0000-0001-7995-4226
Qiang WangThe State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China. wangq@nju.edu.cn.ORCID 0000-0003-2907-9851
Qihan ChenFaculty of Health Sciences, University of Macau, Macau SAR, China. lyonchen@umac.mo.ORCID 0000-0002-0062-8434

Funding

Beijing Health Promotion Association (BJHPA) BJHPA-FW-XHKT-2020040400344Chinese Society of Clinical Oncology (CSCO) Y-MSDPU2021-0190,Y-MSD2020-0270Fundo para o Desenvolvimento das Ciências e da Tecnologia (FDCT) 0102/2024/AFJMinistry of Science and Technology of the People's Republic of China, Special Data Service for Oncology, and the National Population and Health Scientific Data Sharing Platform NCMI-ABD02-201809,NCMI-YF02N-201906MOE | Fundamental Research Funds for the Central Universities (Fundamental Research Fund for the Central Universities) 021414380507National High-Level Hospital Clinical Oncology fund 2022-PUMCH-B-011,2022-PUMCH-A-188National Key R&D Program of China 2021YFC2701603
6 · The paper itself

Abstract

The impact of early-stage tumors on gene expression in adjacent tissues remains uncertain, despite the known influence of the tumor microenvironment on tumor progression. Here, we systematically analyze early-stage lung adenocarcinoma (LUAD) and surrounding tissues across multiple distinct regions, from the tumor core to distant tissues. DNA methylation profiling in a 12-patient cohort reveals two distinct patterns of methylation changes. Steep changes occurring at the tumor boundary and shallow changes showing a gradual shift over increasing distance to the tumor. Approximately 17,000 CpG sites demonstrate shallow changing trends without clear boundaries, potentially affecting 2655 genes. In half of the patients, tissues within 10 mm beyond the tumor show methylation patterns similar to tumors. We test mRNA expression of key genes affected by these methylation patterns and observe that the protein expression pattern of WNT7B demonstrates no steep changes at the tumor boundary, supporting their regulatory role. Adding a 59-patient four-year-prognosis cohort allowed us to rigorously assess the clinical relevance of these methylation change trends. These shallow changes reflect tumor characteristics and have the potential for prognostic prediction in patients, warranting further investigation.

Indexed as

AdenocarcinomaDNA MethylationGene Expression Regulation, NeoplasticLung NeoplasmsAdenocarcinoma of LungAgedCohort StudiesCpG IslandsFemaleGene Expression ProfilingHumansMaleMiddle AgedNeoplasm StagingPrognosisWnt ProteinsWnt ProteinsDNA MethylationLung AdenocarcinomamRNA ExpressionPrognosis PredictionTumor Boundary

Identifiers

PMID41184502
PMCPMC12678790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.